StockData
CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc. (CASIF) stock

CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 1/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

CASI Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

CASI Pharmaceuticals's price to sales ratio was 0.1× on Oct 19, 2026, against 0.8× a year earlier. Over the last 5 years it ranged from 0.1× to 7.8×, with a median of 1.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.1×−0.4
2025Dec 31, 20250.5×−0.7
2024Dec 31, 20241.1×−1.1
2023Dec 29, 20232.2×+1.4
2022Dec 30, 20220.8×−5.0
2021Dec 31, 20215.8×–

More CASI Pharmaceuticals figures

See a number that looks wrong?